CTSI Funding Opportunities
https://www.indianactsi.org/grantinfo
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Grant Application Process
•RFP/RFA is released on CTSI Hub and Grant Software
Step 1
•Applicants create and submit proposal via Grant Software
Step 2
•Reviewers access and submit evaluation and scores via Grant
Step 3 Software
Step 4
• Applicants access results and comments via Grant Software
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
CTR Grants
(Collaborative Translational Research)
Summary: This award is to foster collaborations between investigators at IUB,
Purdue, ND, IUSM, and IUPUI in translational research projects with
strong potential to develop into externally funded programs or IP.
Award amount: $75,000 max. (split between collaborators)
Project period: 1-year (+ 1-year NCE)
Qualifications: Projects must have participation by two (or more) principal
investigators representing at least two CTSI partner
institutions
Schedule for award: RFA – March  Applications Due ~ May  Awards
Announced August
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Project Development Teams
Summary: Provides grant writing mentoring, IRB and IP advice, identifies
partners. Can also provide funding to support development of
preliminary data for external grant submissions.
Award amount: $10,000 max.
Project period: 1-year (+ 1-year NCE)
Qualifications: Translational research, external funding strategy, PU-PDT
(predominantly preclinical research) can partner with other PDTs
to meet expertise requirements.
Schedule for award: Rolling application process, no set deadline.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Core Pilot Funding
(CTSI-designated Core facilities)
Summary: Promotes use of CTSI cores across CTSI partner institutions and
supports science with a high potential for external funding or IP.
Funds are used as an expense account at the Core facility. No other
expenses qualify.
Award amount: $10,000 max.
Project period: 2-year (+ 1-year NCE)
Qualifications: Translational research, external funding strategy, the Core does
not need to be from the faculty’s home institution
Schedule for award: RFA: March/August  Applications Due: May/October

Awards Announced: July/December
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Research Inventions and Scientific
Commercialization (RISC)
Summary: Pilot program to support, foster and encourage cutting edge
scientific potential breakthroughs and technology development that
will serve as the foundation for new business enterprises and / or
promote the advancement of translational research or health related
objectives.
Award amount: $25,000 max.
Project period: 1-year
Qualifications: Open to basic and clinical translationsl researchers indentified
by the IU Emerging Technologies Center (IUETC)
Schedule for award: Rolling application process, no set deadline.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Midwest Strategic Pharma-Academic
Research Consortium Research
Awards Program (SPARC)
Summary: This award is to foster collaborations between academics and
pharmas in translational research projects in the area of human
Autoimmune Diseases.
Award amount: TBA
Project period: 2-year
Qualifications: Projects must have participation by two (or more) principal
investigators representing at least two SPARC partner institutions
Schedule for award: TBD
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Indiana Clinical Research Center at Purdue
Wayne Campbell, PhD, Director
campbellw@purdue.edu (765)- 494-8236
Clinical Services
Bio-Nutrition Services
•Blood, Urine, & Muscle Sampling
•Stable Isotope Infusions
•Ingestive Behavior & Sensory
Evaluation
•Exercise Training & Physical
Fitness Assessment
•Menu Development
•Dietary Counseling
•Meal Preparation & Service
•Computerized Nutritional Analysis
•Dietary Homogenate Prep. & Analysis
•Dietary and Metabolic
Balance Protocols
Body Composition
And Imaging Services
•Bone/Soft Tissue (DXA)
•Whole Body Volume (plethysmography)
•Whole Body Water (isotope dilution)
•Bone Geometry (pQCT)
•Micro Computed Tomography
•Body Tissues (MRI, MRS, fMRI)
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
CHEP Community Based Pilot
Projects
Summary: Collaborative, community-based research projects: Program
evaluation, feasibility or preliminary data for extramural grant
submissions. Applicants are encouraged to identify, or further develop,
collaborative relationships to be strengthened.
Award amount: $15,000-$30,000 per project. $100,000 total available
Project period: 1-year
Qualifications: MUST be both an academic partner and an community partner
on the project. Both partners must currently be working in an
Indiana-based institution / organization.
Schedule: RFA – April  Due May 16  Awards August 8th
Website: https://www.indianactsi.org/grantinfo/grant/150
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org
Biomedical Engineering
and Bionanotechnology
Advise and facilitate the invention, innovation, and testing of medical devices
(from nano to macro) through the technology development process.
• Medical Device Design, Prototyping, and Evaluation
–
•
Nanotechnology Approaches and Therapeutics Development
–
•
Trials utilize spontaneous, naturally-occurring disease models; Studies evaluate devices,
drugs, nutritional programs; Pathologies range from cancer to orthopedic
Preclinical Studies Planning, Coordination and Implementation
–
•
Nanomaterial core construction and nanometrology measurements; Targeting and therapeutic
molecule development; In vitro and in vivo testing of cell-nanomedical system interactions
Veterinary Clinical Trials
–
•
Extensive facilities for materials and electronic fabrication; Experience in implantable
electronic, optical, mechanical, acoustical sensors; Dedicated experimental design and
evaluation protocol development
Expertise in a wide variety of animal models and procedures; Pre-study planning and new
protocol development; Extensive training and study capabilities; Complete after care in
recovery studies
Histology and Phenotyping
–
Extensive history with implantable device evaluation; Both soft and hard tissue capabilities;
Experienced with device, drug and toxicologic, and infectious disease pathologies
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
www.indianactsi.org